Brief: Cardiff Oncology Reports First Quarter 2022 Results And Provides Business Updates
05/05/2022 23:49
May 5 (Reuters) - Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY REPORTS FIRST QUARTER 2022 RESULTS AND
PROVIDES
BUSINESS UPDATES
* CARDIFF ONCOLOGY INC - CASH, CASH EQUIVALENTS, AND
SHORT-TERM
INVESTMENTS OF APPROXIMATELY $129.4 MILLION AS OF MARCH 31, 2022
Source text for Eikon: ID:nPn3ycpM5a
Further company coverage: CRDF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering